US08773T1043 - Common Stock
BETTER THERAPEUTICS INC
NASDAQ:BTTX (3/15/2024, 8:00:03 PM)
After market: 0.036 -0.01 (-19.28%)0.0446
+0.01 (+27.43%)
Better Therapeutics, Inc. operates as a digital therapeutics company, which engages in developing a novel form of cognitive behavioral therapy to address the root causes of cardio metabolic diseases. The company is headquartered in San Francisco, California and currently employs 54 full-time employees. The company went IPO on 2021-01-08. The firm is engaged in developing a novel form of cognitive behavioral therapy (CBT) to address the root causes of cardiometabolic diseases. Its lead PDT product candidate, BT-001, is an investigational prescription digital therapy for the treatment of T2D. The investigational therapy is delivered via software that provides a tailored experience to patients designed to help them address the underlying causes of T2D by making meaningful, sustainable behavioral changes. The BT-001 investigational therapy is rooted in the well-studied, gold standard of behavioral modification therapies, cognitive behavioral therapy (CBT). The firm's platform consists of three behavioral therapy, treatment plans and personalization. Its behavioral therapy consists of lessons, skill- building modules, and a mechanism for goal setting. Its treatment plan is the primary engagement interface for patients.
BETTER THERAPEUTICS INC
548 Market St. #49404
San Francisco CALIFORNIA
P: 14158872311
CEO: Suying Liu
Employees: 54
Website: https://www.bettertx.com/
It's time to start the final day of trading this week with a look into the biggest pre-market stock movers for Friday morning!
Here you can normally see the latest stock twits on BTTX, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: